{"id":"W4403763220","doi":"10.1016/j.ejca.2024.114974","title":"467 (PB455): IND.241: A Canadian Cancer Trials Group liquid-biopsy informed platform trial to evaluate treatment in CDK4/6-inhibitor resistant ER +/HER2- metastatic breast cancer","year":2024,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Medicine; Oncology; Internal medicine; Breast cancer; Metastatic breast cancer; HER2 negative; Clinical trial; Cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009413885,0.0009454695,0.0009199042,0.0002795324,0.0005677335,0.000917532,0.0008522775,0.00148412,0.01740077],"category_scores_gemma":[0.0009694527,0.0002692465,0.0007689133,0.0003829977,0.0007958361,0.0004522872,0.0004107207,0.003051084,0.002104163],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002674566,"about_ca_system_score_gemma":0.005279446,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.04278295,"about_ca_topic_score_gemma":0.1437871,"domain_scores_codex":[0.9996067,0.0001635512,0.000007562849,0.00004263251,0.00005743794,0.0001222672],"domain_scores_gemma":[0.9996337,0.00004385581,0.00003860275,0.00002300738,0.00002587438,0.0002349761],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6352975,0.01105438,0.002516777,0.001077509,0.001339986,0.000311484,0.0001751217,0.002292089,0.01081531,0.003022233,0.08046341,0.2516343],"study_design_scores_gemma":[0.8434023,0.08878969,0.01731689,0.00030142,0.0007210703,0.0002506183,0.0001539153,0.002060303,0.001511448,0.001845583,0.04357737,0.00006935811],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8461187,0.01431964,0.001770912,0.01344807,0.001370284,0.008821842,0.02600125,0.0008918305,0.08725753],"genre_scores_gemma":[0.9394408,0.004990441,0.003207531,0.008693378,0.0003144711,0.002636721,0.0128225,0.0001185422,0.02777559],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9973254,"threshold_uncertainty_score":0.08506787,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06766777546693979,"score_gpt":0.3837883612864939,"score_spread":0.316120585819554,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}